Lawyers USA Your Business Partner

Some birth control associated with increased blood clot risk 

Published: May 18, 2012

Tags: birth control, birth control litigation, birth control patch, blood clots, drug litigation, Johnson & Johnson, Merck, Nuvaring, Ortho-Evra, product liability

Women who use birth control patches like Ortho-Evra or contraceptive vaginal rings like NuvaRing have a heightened risk of blood clots, a new medical study has found.

Ruling may save suits against generic drug makers 

By: Sylvia Hsieh
Published: May 9, 2012

Tags: drug litigation, failure to warn, Federal Food Drug and Cosmetic Act, federal preemption, generic drug litigation, generic drugs, PLIVA v. Mensing, preemption, product liability, Wyeth v. Levine

Since last year, when generic drug makers won a victory on the issue of federal preemption before the U.S. Supreme Court, lower courts have been dismissing cases against generic drug makers left and right.

But last week a federal appeals court issued a ruling that gives plaintiffs a long-awaited opening in those suits.

Woman wins $4 million in Prempro breast cancer trial 

By: Sylvia Hsieh
Published: April 27, 2012

Tags: breast cancer, drug litigation, hormone replacement therapy, HRT litigation, Pfizer, Prempro, Wyeth

A 65-year-old elementary school principal has won a $4 million verdict in Connecticut federal court against the maker of the menopause drug Prempro for causing her breast cancer.

First Pradaxa suits filed in federal court 

Published: March 26, 2012

Tags: atrial fibrillation, blood thinners, drug litigation, FDA, Food and Drug Administration, Pradaxa, product liability

What are believed to be the first three product liability suits over the blood thinner Pradaxa were filed earlier this month in federal courts in Kentucky, Louisiana and Tennessee.

Accutane litigation grows 

By: Correy Stephenson
Published: March 7, 2012

Tags: Accutane, drug litigation, multi-district litigation

After more than a decade, the litigation against Hoffman-LaRoche, the maker of the acne drug Accutane, continues to grow.

More than 7,000 cases are currently on file in multi-district litigation consolidated in New Jersey state court, and both sides continue to vigorously litigate with no settlement negotiations in sight.

Lawsuit alleges drug Effexor caused fatal birth defect 

Published: February 17, 2012

Tags: birth defects, drug litigation, Effexor, FDA, Food and Drug Administration, Pfizer, product liability, Wyeth Pharmaceuticals

In what is believed to be the first lawsuit of its kind, an Ohio woman is claiming that her ingestion of the popular anti-depressant Effexor during pregnancy caused a fatal birth defect in her daughter.

Cymbalta caused dangerous skin condition, lawsuit says 

Published: January 30, 2012

Tags: Cymbalta, defective design, drug litigation, Eli Lilly, FDA, Food and Drug Administration, Stevens-Johnson Syndrome, strict liability

A Kansas woman has filed a product liability suit against Eli Lilly, claiming she suffered a life-threatening skin condition known as Stevens-Johnson syndrome as a result of taking the drug company’s anti-depressant Cymbalta.

Glaxo, U.S. reach tentative $3B deal over Avandia 

Published: November 17, 2011

Tags: Avandia, Department of Justice, diabetes, drug litigation, GlaxoSmithKline, off-label uses

GlaxoSmithKline has announced a tentative deal with the federal government under which the drug company would pay a record $3 billion to end an investigation into the marketing of Avandia for “off-label” uses.

Deadline approaches for certain fen-phen claims 

Published: August 29, 2011

Tags: class action, drug litigation, fen-phen

A Dec. 31, 2011 deadline in the fen-phen litigation faces certain individuals who may be eligible for additional cash payments from the $4.8 billion nationwide class settlement involving the recalled diet drug.

Darvon, Darvocet liability suits consolidated in federal court 

Published: August 26, 2011

Tags: Darvocet, Darvon, drug litigation, MDL, multidistrict litigation

A federal judicial panel has consolidated product liability suits involving the popular pain medications Darvon and Darvocet in the U.S. District Court for the Eastern District of Kentucky.